Synthesis of multivalent lactose derivatives by 1,3-dipolar cycloadditions: selective galectin-1 inhibition
- PMID: 16697988
- DOI: 10.1016/j.carres.2006.04.028
Synthesis of multivalent lactose derivatives by 1,3-dipolar cycloadditions: selective galectin-1 inhibition
Abstract
Acetylene derivatives of phenylalanine, phenethylamine and the multifunctional unnatural amino acids, phenyl-bis-alanine and phenyl-tris-alanine, were synthesized and functionalized with 2-azidoethyl beta-D-galactopyranosyl-(1-->4)-beta-D-glucopyranoside via regioselective copper(I)-mediated 1,3-dipolar cycloaddition to give a panel of mono-, di- and trivalent lactoside derivatives. Evaluation of the compounds as inhibitors against the tumour- and inflammation-related galectin-1, -3, -4N, -4C, -4, -7, -8N and -9N revealed a divalent compound with a Kd value as low as 3.2 microM for galectin-1, which corresponded to a relative potency of 30 per lactose unit as compared to the natural disaccharide ligand lactose. This divalent compound had at least one order of magnitude higher affinity for galectin-1 than for any of the other galectins investigated.
Similar articles
-
Synthesis of stable and selective inhibitors of human galectins-1 and -3.Bioorg Med Chem. 2008 Aug 15;16(16):7811-23. doi: 10.1016/j.bmc.2008.06.044. Epub 2008 Jun 26. Bioorg Med Chem. 2008. PMID: 18674915
-
Synthesis of deoxy and acylamino derivatives of lactose and use of these for probing the active site of Neisseria meningitidis N-acetylglucosaminyltransferase.Carbohydr Res. 2005 Feb 7;340(2):221-33. doi: 10.1016/j.carres.2004.11.017. Carbohydr Res. 2005. PMID: 15639242
-
Synthesis of a phenyl thio-beta-D-galactopyranoside library from 1,5-difluoro-2,4-dinitrobenzene: discovery of efficient and selective monosaccharide inhibitors of galectin-7.Org Biomol Chem. 2005 May 21;3(10):1922-32. doi: 10.1039/b502354h. Epub 2005 Apr 14. Org Biomol Chem. 2005. PMID: 15889175
-
An updated patent review of galectin-1 and galectin-3 inhibitors and their potential therapeutic applications (2016-present).Expert Opin Ther Pat. 2021 Aug;31(8):709-721. doi: 10.1080/13543776.2021.1903430. Epub 2021 May 20. Expert Opin Ther Pat. 2021. PMID: 33749494 Review.
-
Galectin-1 inhibitors and their potential therapeutic applications: a patent review.Expert Opin Ther Pat. 2016 May;26(5):537-54. doi: 10.1517/13543776.2016.1163338. Epub 2016 Mar 25. Expert Opin Ther Pat. 2016. PMID: 26950805 Review.
Cited by
-
Characterization of a neutralizing anti-human galectin-1 monoclonal antibody with angioregulatory and immunomodulatory activities.Angiogenesis. 2021 Feb;24(1):1-5. doi: 10.1007/s10456-020-09749-3. Epub 2020 Oct 1. Angiogenesis. 2021. PMID: 33006019
-
Crystallization and preliminary crystallographic analysis of recombinant human galectin-1.Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 Nov 1;63(Pt 11):967-71. doi: 10.1107/S1744309107050142. Epub 2007 Oct 24. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007. PMID: 18007053 Free PMC article.
-
Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection.Antimicrob Agents Chemother. 2012 Jan;56(1):154-62. doi: 10.1128/AAC.05595-11. Epub 2011 Nov 7. Antimicrob Agents Chemother. 2012. PMID: 22064534 Free PMC article.
-
Aromatic heterocycle galectin-1 interactions for selective single-digit nM affinity ligands.RSC Adv. 2018 Jul 11;8(44):24913-24922. doi: 10.1039/c8ra04389b. eCollection 2018 Jul 9. RSC Adv. 2018. PMID: 35542159 Free PMC article.
-
Structure-based optimization of angiostatic agent 6DBF7, an allosteric antagonist of galectin-1.J Pharmacol Exp Ther. 2013 Mar;344(3):589-99. doi: 10.1124/jpet.112.199646. Epub 2012 Dec 11. J Pharmacol Exp Ther. 2013. PMID: 23232447 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous